loader
Please Wait
Applying Filters...

Annual Sales of 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (alphaS)- reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 66Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5E Keppra

02 6Keppra

PharmaCompass

01

Brand Name : Keppra

Levetiracetam

arrow
Formnext Forum
Not Confirmed

Brand Name : Keppra

arrow
Formnext Forum
Not Confirmed

Levetiracetam

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 839

2018 Revenue in Millions : 860

Growth (%) : -2

blank

02

Brand Name : E Keppra

Levetiracetam

arrow
Formnext Forum
Not Confirmed

Brand Name : E Keppra

arrow
Formnext Forum
Not Confirmed

Levetiracetam

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 406

2019 Revenue in Millions : 444

Growth (%) : -9

blank

03

Brand Name : Keppra

Levetiracetam

arrow
Formnext Forum
Not Confirmed

Brand Name : Keppra

arrow
Formnext Forum
Not Confirmed

Levetiracetam

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 953

2019 Revenue in Millions : 931

Growth (%) : 2

blank

04

Brand Name : Keppra

Levetiracetam

arrow
Formnext Forum
Not Confirmed

Brand Name : Keppra

arrow
Formnext Forum
Not Confirmed

Levetiracetam

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 1,068

2020 Revenue in Millions : 953

Growth (%) : 23

blank

05

Brand Name : Keppra

Levetiracetam

arrow
Formnext Forum
Not Confirmed

Brand Name : Keppra

arrow
Formnext Forum
Not Confirmed

Levetiracetam

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 777

2021 Revenue in Millions : 1,068

Growth (%) : -27

blank

06

Brand Name : Keppra

Levetiracetam

arrow
Formnext Forum
Not Confirmed

Brand Name : Keppra

arrow
Formnext Forum
Not Confirmed

Levetiracetam

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 686

2022 Revenue in Millions : 776

Growth (%) : 14

blank

07

Brand Name : E Keppra

Levetiracetam

arrow
Formnext Forum
Not Confirmed

Brand Name : E Keppra

arrow
Formnext Forum
Not Confirmed

Levetiracetam

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 261

2015 Revenue in Millions : 207

Growth (%) : 26

blank

08

Brand Name : E Keppra

Levetiracetam

arrow
Formnext Forum
Not Confirmed

Brand Name : E Keppra

arrow
Formnext Forum
Not Confirmed

Levetiracetam

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 324

2016 Revenue in Millions : 274

Growth (%) : 19

blank

09

Brand Name : E Keppra

Levetiracetam

arrow
Formnext Forum
Not Confirmed

Brand Name : E Keppra

arrow
Formnext Forum
Not Confirmed

Levetiracetam

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 363

2017 Revenue in Millions : 304

Growth (%) : 19%

blank

10

Brand Name : E Keppra

Levetiracetam

arrow
Formnext Forum
Not Confirmed

Brand Name : E Keppra

arrow
Formnext Forum
Not Confirmed

Levetiracetam

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 435

2018 Revenue in Millions : 375

Growth (%) : 16

blank